Molecular and pharmacological characterization of GABAA receptor α1 subunit knockout mice

被引:149
作者
Kralic, JE
Korpi, ER
O'Buckley, TK
Homanics, GE
Morrow, AL
机构
[1] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA
[4] Univ Turku, Dept Pharmacol & Clin Pharmacol, Turku, Finland
[5] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1124/jpet.102.036665
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
GABA(A) receptors mediate fast inhibitory neurotransmission in the central nervous system (CNS), and approximately half of these receptors contain alpha1 subunits. GABA(A) receptor alpha1 subunits are important for receptor assembly and specific pharmacological responses to benzodiazepines. Plasticity in GABA(A) receptor alpha1 subunit expression is associated with changes in CNS excitability observed during normal brain development, in animal models of epilepsy, and upon withdrawal from alcohol and benzodiazepines. To examine the role of alpha1 subunit-containing GABA(A) receptors in vivo, we characterized receptor subunit expression and pharmacological properties in cerebral cortex of knockout mice with a targeted deletion of the alpha1 subunit. The mice are viable but exhibit an intention tremor. Western blot analysis confirms the complete loss of alpha1 subunit peptide expression. Stable adaptations in the expression of several GABA(A) receptor subunits are observed in the fifth to seventh generations, including decreased expression of beta2/3 and gamma2 subunits and increased expression of alpha2 and alpha3 subunits. There was no change in alpha4, alpha5, or delta subunit peptide levels in cerebral cortex. Knockout mice exhibit loss of over half of GABA(A) receptors measured by [H-3]muscimol, [H-3]2-(3-carboxyl)-3-amino-6-(4-methoxyphenyl)-pyridazinium bromide ([H-3]SR-95531), and t-butylbicyclophosphoro[S-35]thionate ([S-35]TBPS) binding. [H-3]Ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate ([H-3]Ro15-4513) binding is reduced by variable amounts in different regions across brain. GABA(A) receptor alpha1(-/-) mice lose all high-affinity [H-3] zolpidem binding and about half of [H-3] flunitrazepam binding in the cerebral cortex. The potency and maximal efficacy of muscimol-stimulated Cl-36(-) uptake in cerebral cortical synaptoneurosomes are reduced in alpha1(-/-) mice. Furthermore, knockout mice exhibit increased bicuculline-induced seizure susceptibility compared with wild-type mice. These data emphasize the significance of alpha1 subunit expression and its involvement in the regulation of CNS excitability.
引用
收藏
页码:1037 / 1045
页数:9
相关论文
共 56 条
[1]   CONVULSIVE STATUS EPILEPTICUS IN INFANTS AND CHILDREN - A STUDY OF 239 CASES [J].
AICARDI, J ;
CHEVRIE, JJ .
EPILEPSIA, 1970, 11 (02) :187-&
[2]  
Barnard EA, 1998, PHARMACOL REV, V50, P291
[3]   Pharmacology of recombinant γ-aminobutyric acida receptors rendered diazepam-insensitive by point-mutated α-subunits [J].
Benson, JA ;
Löw, K ;
Keist, R ;
Mohler, H ;
Rudolph, U .
FEBS LETTERS, 1998, 431 (03) :400-404
[4]   [H-3]-LABELED PROPYL BETA-CARBOLINE-3-CARBOXYLATE AS A SELECTIVE RADIOLIGAND FOR THE BZ1 BENZODIAZEPINE RECEPTOR SUBCLASS [J].
BRAESTRUP, C ;
NIELSEN, M .
JOURNAL OF NEUROCHEMISTRY, 1981, 37 (02) :333-341
[5]   Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy [J].
Brooks-Kayal, AR ;
Shumate, MD ;
Jin, H ;
Rikhter, TY ;
Coulter, DA .
NATURE MEDICINE, 1998, 4 (10) :1166-1172
[6]   ANTISENSE OLIGONUCLEOTIDE-INDUCED BLOCK OF INDIVIDUAL GABA(A) RECEPTOR-ALPHA SUBUNITS IN CULTURED VISUAL-CORTEX SLICES REDUCES AMPLITUDE OF EVOKED INHIBITORY POSTSYNAPTIC CURRENTS [J].
BRUSSAARD, AB ;
BAKER, RE .
NEUROSCIENCE LETTERS, 1995, 191 (1-2) :111-115
[7]  
Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924
[8]   Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues [J].
Crestani, F ;
Lorez, M ;
Baer, K ;
Essrich, C ;
Benke, D ;
Laurent, JP ;
Belzung, C ;
Fritschy, JM ;
Lüscher, B ;
Mohler, H .
NATURE NEUROSCIENCE, 1999, 2 (09) :833-839
[9]   Mechanism of action of the hypnotic zolpidem in vivo [J].
Crestani, F ;
Martin, JR ;
Möhler, H ;
Rudolph, U .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (07) :1251-1254
[10]  
DeLorey TM, 1998, J NEUROSCI, V18, P8505